Literature DB >> 31903636

miR-142-5p protects against osteoarthritis through competing with lncRNA XIST.

Pengfei Sun1, Yunpeng Wu1, Xuezhou Li1, Yuhua Jia1.   

Abstract

BACKGROUND: The relevance between abnormal microRNA expression and osteoarthritis (OA) has been elaborated in recent studies. Hence, the present study aimed to assess the impact of miR-142-5p on chondrocyte growth and apoptosis.
METHODS: To mimic OA-like chondrocyte damage, interleukin (IL)-1β was used for chondrocyte treatment. The expression of miR-142-5p, SGTB, long non-coding RNA (lncRNA) X inactive specific transcript (XIST) and involved molecules such as Col2A1, Bcl-2, MMP13 and Bax was determined via a quantitative reverse transcriptase-polymerase chain reaction and western blot analyses. Functional roles of miR-142-5p, SGTB and XIST were monitored in 5-ethynyl-2'-deoxyuridine, CCK-8 and TUNEL experiments. Rescue analyses were conducted to consolidate the effect of the XIST/miR-142-5p/SGTB axis on chondrocytes in OA.
RESULTS: miR-142-5p was down-regulated in IL-1β-treated chondrocytes, whereas SGTB and XIST levels were increased. Overexpression of miR-142-5p stimulated proliferation and retarded apoptosis in IL-1β-treated chondrocytes. Meanwhile, miR-142-5p elevation was correlated with an elevation of Col2A1 and Bcl-2, as well as a decline of MMP13 and Bax. A mechanistic study showed that miR-142-5p negatively regulated SGTB expression. Moreover, we found that lncRNA XIST could relieve the inhibition of miR-142-5p on SGTB expression. Augmentation of SGTB or suppression of miR-142-5p reversed the influence of XIST depletion on chondrocyte growth and apoptosis.
CONCLUSIONS: The present study has explored the fundamental role of miR-142-5p in IL-1β-treated chondrocytes, as well as the novel molecular mechanism constituted by miR-142-5p/SGTB/XIST in OA. Potentially, the results obtained may add new insight into OA pathogenesis.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  OA; SGTB; XIST; miR-142-5p

Mesh:

Substances:

Year:  2020        PMID: 31903636     DOI: 10.1002/jgm.3158

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  LncRNA XIST accelerates burn wound healing by promoting M2 macrophage polarization through targeting IL-33 via miR-19b.

Authors:  Li Pi; Bairong Fang; Xianxi Meng; Li Qian
Journal:  Cell Death Discov       Date:  2022-04-21

Review 2.  The Emerging Role of Non-Coding RNAs in Osteoarthritis.

Authors:  Soudeh Ghafouri-Fard; Christophe Poulet; Michel Malaise; Atefe Abak; Bashdar Mahmud Hussen; Afshin Taheriazam; Mohammad Taheri; Mohammad Hallajnejad
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

3.  Circular RNA RHOT1 Regulates miR-142-5p/CCND1 to Participate in Chondrocyte Autophagy and Proliferation in Osteoarthritis.

Authors:  Gu Man; Haiwen Yang; Kai Shen; Donghong Zhang; Julin Zhang; Hao Wu; Hongyu Zhang; Jinhuan Wang
Journal:  J Immunol Res       Date:  2022-03-08       Impact factor: 4.818

4.  Autophagy-Related Genes Predict the Progression of Periodontitis Through the ceRNA Network.

Authors:  Mengyao Bian; Wenhao Wang; Chengjie Song; Lai Pan; Yanmin Wu; Lili Chen
Journal:  J Inflamm Res       Date:  2022-03-11

5.  Role of lincRNA-Cox2 targeting miR-150 in regulating the viability of chondrocytes in osteoarthritis.

Authors:  Meng Jiang; Kai Xu; Huafeng Ren; Mingmin Wang; Ximin Hou; Jianping Cao
Journal:  Exp Ther Med       Date:  2021-05-25       Impact factor: 2.447

Review 6.  Biological Function of Long Non-coding RNA (LncRNA) Xist.

Authors:  Wenlun Wang; Lu Min; Xinyuan Qiu; Xiaomin Wu; Chuanyang Liu; Jiaxin Ma; Dongyi Zhang; Lingyun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-10

7.  Circ_0005526 contributes to interleukin-1β-induced chondrocyte injury in osteoarthritis via upregulating transcription factor 4 by interacting with miR-142-5p.

Authors:  Paerhati Wahafu; Aixian Xu; Bo Zhao; Yanan Tuo; Junkui Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.